Single-Dose Pharmacokinetics of Amprenavir Coadministered with Grapefruit Juice

AUTOR(ES)

Demarles, D.

FONTE

American Society for Microbiology

RESUMO

In this crossover study in 12 healthy volunteers, coadministration of amprenavir (1,200 mg; single dose) with grapefruit juice slightly reduced the maximum concentration of drug in serum (Cmax) compared to administration with water (7.11 versus 9.10 μg/ml), slightly increased the time to Cmax (1.13 versus 0.75 h), and did not affect the area under the concentration-time curve from 0 to 12 h (AUC0-12), the AUC0-∞, or the concentration at 12 h. Therefore, grapefruit juice does not clinically significantly affect amprenavir pharmacokinetics.

Documentos Relacionados

• Single-dose pharmacokinetics of acyclovir.
• Single-dose pharmacokinetics of cefsulodin in patients with cystic fibrosis.
• Single-dose pharmacokinetics of imipenem-cilastatin in neonates.
• Single-dose pharmacokinetics of aztreonam in pediatric patients.
• Imipenem coadministered with cilastatin compared with moxalactam: integration of serum pharmacokinetics and microbiologic activity following single-dose administration to normal volunteers.